FactSet's stock has risen 17% in six months, but growth rates are slowing down, and the stock appears overvalued again. Fiscal 2024 results show solid growth, but future growth rates are expected to ...
FactSet's high client retention rate and diverse revenue streams make it a strong buy, despite its high valuation. Recent product expansions, including GenAI solutions and IRN 2.0, enhance FactSet's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results